Public COA audit

Retatrutide · Retatrutide 10mg

Audited July 29, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
88
Confidence
92%
Panels
2/7
Purity (printed)
99.857%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
Black Cap
Identity method
GLP RT
Sample date
2026-03-20
Issue date
2026-03-22

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

2 of 7 present · 2 passed · 0 failed · 0 reported · 5 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    GLP RT confirmed, mass spec peaks at m/z 1183.60 [M+4H]4+ and 1578.05 [M+3H]3+

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.857%

  • Heavy metals

    Not on this COA

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Not on this COA · core

    LAL or chromogenic endotoxin assay.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Sterility

    Not on this COA

    Sterility testing where applicable.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    99.857% purity by HPLC-UV-MS is excellent and typical for research-grade peptides

  • Identity confirmed by mass spectrometry

    Mass spec shows expected charge states for retatrutide with peaks at m/z 1183.60 [M+4H]4+ and 1578.05 [M+3H]3+, consistent with molecular weight ~4728 Da

  • Dates are reasonable

    Received 2026-03-20, reported 2026-03-22 (2-day turnaround is normal)

  • Lab information present

    Freedom Diagnostics with searchable URL and contact information provided

  • Lot number is generic

    Lot listed as 'Black Cap' which is descriptive rather than a standard alphanumeric batch identifier

  • Limited testing scope

    Only identity and purity panels performed; no heavy metals, microbial, endotoxin, sterility, or solvent/water content testing

  • Professional presentation

    Document includes chromatogram, mass spectrum, product photo, disclaimer text, and proper labeling

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.